INTENSIFIED MRI-BASED PROSTATE CANCER SCREENING IN GERMLINE CARRIERS OF RARE PATHOGENIC VARIANTS: INTERIM RESULTS FROM THE INITIAL SCREENING ROUND OF THE PROGRESS STUDY

被引：0
|
作者：
Andrew, Amini [1 ]
Alexandra, Hunter [1 ]
Aya, Almashad [1 ]
Aileen, Feng J. [1 ]
Neel, Patel D. [1 ]
Shelley, McCormick R. [1 ]
Linda, Rodgers H. [1 ]
Keyan, Salmi [1 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷
关键词：
D O I：
10.1016/j.urolonc.2024.01.255
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
218
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 21 条
  • [1] INTENSIFIED PROSTATE CANCER SCREENING IN GERMLINE CARRIERS OF RARE PATHOGENIC VARIANTS: INTERIM RESULTS FROM THE INITIAL SCREENING ROUND OF THE PROGRESS STUDY
    Salari, Keyan
    Hunter, Alexandra
    Amini, Andrew
    Almashad, Aya
    McCormick, Shelley
    Rodgers, Linda
    JOURNAL OF UROLOGY, 2023, 209 : E549 - E549
  • [2] Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study
    Amini, Andrew E.
    Hunter, Alexandra E.
    Almashad, Aya
    Feng, Aileen J.
    Patel, Neel D.
    O'Dea, Margaret R.
    Mccormick, Shelley R.
    Rodgers, Linda H.
    Salari, Keyan
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (06):
  • [3] IMPACT study - Targeted prostate cancer screening for rare germline mutation carriers
    Mikropoulos, C.
    Page, E.
    Bancroft, L.
    Taylor, N.
    Ahmed, M.
    Eeles, R.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S116 - S116
  • [4] Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
    Bancroft, Elizabeth K.
    Page, Elizabeth C.
    Castro, Elena
    Lilja, Hans
    Vickers, Andrew
    Sjoberg, Daniel
    Assel, Melissa
    Foster, Christopher S.
    Mitchell, Gillian
    Drew, Kate
    Maehle, Lovise
    Axcrona, Karol
    Evans, D. Gareth
    Bulman, Barbara
    Eccles, Diana
    McBride, Donna
    van Asperen, Christi
    Vasen, Hans
    Kiemeney, Lambertus A.
    Ringelberg, Janneke
    Cybulski, Cezary
    Wokolorczyk, Dominika
    Selkirk, Christina
    Hulick, Peter J.
    Bojesen, Anders
    Skytte, Anne-Bine
    Lam, Jimmy
    Taylor, Louise
    Oldenburg, Rogier
    Cremers, Ruben
    Verhaegh, Gerald
    van Zelst-Stams, Wendy A.
    Oosterwijk, Jan C.
    Blanco, Ignacio
    Salinas, Monica
    Cook, Jackie
    Rosario, Derek J.
    Buys, Saundra
    Conner, Tom
    Ausems, Margreet G.
    Ong, Kai-ren
    Hoffman, Jonathan
    Domchek, Susan
    Powers, Jacquelyn
    Teixeira, Manuel R.
    Maia, Sofia
    Foulkes, William D.
    Taherian, Nassim
    Ruijs, Marielle
    Helderman-van den Enden, Apollonia T.
    EUROPEAN UROLOGY, 2014, 66 (03) : 489 - 499
  • [5] Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening
    Segal, N.
    Ber, Y.
    Benjaminov, O.
    Tamir, S.
    Yakimov, M.
    Kedar, I
    Rosenbaum, E.
    Sela, S.
    Ozalvo, R.
    Shavit-Grievink, L.
    Keder, D.
    Baniel, J.
    Margel, D.
    ANNALS OF ONCOLOGY, 2020, 31 (11) : 1545 - 1552
  • [6] Final results of the initial and second prostate cancer screening round of the European randomized study of screening for prostate cancer (ERSPC, section Rotterdam)
    Roobol, MJ
    De Vries, SH
    Schröder, FH
    JOURNAL OF UROLOGY, 2004, 171 (04): : 165 - 165
  • [7] A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
    Bancroft, Elizabeth K.
    Page, Elizabeth C.
    Brook, Mark N.
    Thomas, Sarah
    Taylor, Natalie
    Pope, Jennifer
    McHugh, Jana
    Jones, Ann-Britt
    Karlsson, Questa
    Merson, Susan
    Ong, Kai Ren
    Hoffman, Jonathan
    Huber, Camilla
    Maehle, Lovise
    Grindedal, Eli Marie
    Stormorken, Astrid
    Evans, D. Gareth
    Rothwell, Jeanette
    Lalloo, Fiona
    Brady, Angela F.
    Bartlett, Marion
    Snape, Katie
    Hanson, Helen
    James, Paul
    McKinley, Joanne
    Mascarenhas, Lyon
    Syngal, Sapna
    Ukaegbu, Chinedu
    Side, Lucy
    Thomas, Tessy
    Barwell, Julian
    Teixeira, Manuel R.
    Izatt, Louise
    Suri, Mohnish
    Macrae, Finlay A.
    Poplawski, Nicola
    Chen-Shtoyerman, Rakefet
    Ahmed, Munaza
    Musgrave, Hannah
    Nicolai, Nicola
    Greenhalgh, Lynn
    Brewer, Carole
    Pachter, Nicholas
    Spigelman, Allan D.
    Azzabi, Ashraf
    Helfand, Brian T.
    Halliday, Dorothy
    Buys, Saundra
    Cajal, Teresa Ramon Y.
    Donaldson, Alan
    LANCET ONCOLOGY, 2021, 22 (11): : 1618 - 1631
  • [8] Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers to detect clinically significant disease: Results from the initial screening round of the IMPACT study
    Mikropoulos, Christos
    Castro, Elena
    Bancroft, Elizabeth
    Page, Elizabeth
    Taylor, Natalie
    Ahmed, Mahbubl
    Goh, Chee Leng
    Eeles, Ros A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [9] Re: A Prospective Prostate Cancer Screening Programme for Men with Pathogenic Variants in Mismatch Repair Genes (IMPACT): Initial Results from an International Prospective Study
    Fasulo, Vittorio
    Zuradellia, Monica
    Lazzeria, Massimo
    EUROPEAN UROLOGY, 2022, 81 (02) : 216 - 218
  • [10] Re: A Prospective Prostate Cancer Screening Programme for Men with Pathogenic Variants in Mismatch Repair Genes (IMPACT): Initial Results from an International Prospective Study
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2022, 207 (06): : 1350 - 1351
123